Table 2

Table 2. Clinical outcomes of cycles using corifollitropin alfa, and recombinant follicle-stimulating hormone (rRFSH) or highly purified human menopausal gonadotropin (HP-HMG)
	Corifollitropin alfa	rFSH/HP-HMG	P^a
Oocytes yielded, total (mean±SD)	11.99±10	10.9±7.2	NS
Oocytes yielded, MII (mean±SD)	10.3±7.9	8.6±5.7	NS
Fertilization, %	76.9	76.8	NS
Embryos transferred (mean±SD)	1.63±0,84	1.76±0.94	NS
Biochemical pregnancy, %	66.7	47.2	NS
Implantation rate, %	68.7	50	NS
NS = not significant ^a Statistical analysis performed by unpaired t-test (normal distribution) or Mann-Whitney test (non-parametric distribution).